1431 (1431) Fair Value & Analysis

Consumer Defensive · Market cap HK$1.1B

1 1431 1431 · HK

PriceHK$0.2300

Fair ValueHK$0.1786

Upside-22.3%

Quality54/100

Watch 1431 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.1009 – HK$0.2172

Fair value as of: Jul 2, 2026

From 23 valuation models · updated today

Share price −18.2% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2179 – HK$0.4269 · fair‑value band HK$0.1009 – HK$0.2172 · the HK$0.2300 price screens above the HK$0.1786 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1431 (1431) currently trades at HK$0.2300, while our model-based Fair Value estimate is HK$0.1786 — implying the stock looks roughly 22.3% overvalued today. We read business quality at 54/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 1431 generated revenue of HK$2.7B at a net margin of 20.2%. Revenue grew 5.5% year over year. It earns a return on equity of 10.3%. The balance sheet holds a net cash position of HK$109M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$2.7B

Revenue growth (YoY) +5.5%

Net margin 20.2%

Return on equity 10.3%

Free cash flow HK$203M FY2025

P/E ratio 1.6

More key figures

Operating margin 35.0%

EPS (TTM) HK$0.0300

EPS growth (YoY) +159%

Net cash HK$109M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1431 reported revenue of HK$2.7B in FY2025 versus HK$1.8B in FY2021, a compound +10.6%/yr. Reported net income was HK$538M in FY2025, compounding +36.1%/yr from FY2021.

Revenue +10.6%/yr

FY21 HK$1.8B

FY22 HK$2.1B

FY23 HK$2.2B

FY24 HK$2.6B

FY25 HK$2.7B

Net income +36.1%/yr

FY21 HK$157M

FY22 HK$22.8M

FY23 −HK$340M

FY24 HK$297M

FY25 HK$538M

Is 1431 fairly valued? → Check now

Similar stocks

6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Archer-Daniels-Midland Company ADM	$81.28	$38.31	-53%
Muyuan Foods Group 002714	¥33.95	¥119.07	+251%
Bunge Global SA BG	$129.13	$136.85	+6%
2714 2714	HK$31.94	HK$52.68	+65%
Tyson Foods, Inc TSN	$58.73	$34.80	-41%
Wens Foodstuff Group 300498	¥12.89	¥6.35	-51%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1431 (1431) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1786 versus a price of HK$0.2300 — about −22% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1431?

Our model-based fair value for 1431 is HK$0.1786 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2300.

What is the quality score of 1431?

1431 has a Quality Score of 54/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1431 (1431)?

1431 reported trailing-twelve-month revenue of about HK$2.7B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1431?

The net profit margin of 1431 is about 20.2%, meaning it keeps roughly 20.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.